Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban With Unfractionated Heparin + Eptifibatide, in Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy
Conditions
Interventions
Otamixaban
Placebo (for Otamixaban)
+4 more
Locations
607
United States
Investigational Site Number 840015
Huntsville, Alabama, United States
Investigational Site Number 840569
Phoenix, Arizona, United States
Investigational Site Number 840703
Phoenix, Arizona, United States
Investigational Site Number 840101
Anaheim, California, United States
Investigational Site Number 840151
Anaheim, California, United States
Investigational Site Number 840213
Beverly Hills, California, United States
Start Date
April 1, 2010
Primary Completion Date
May 1, 2013
Completion Date
May 1, 2013
Last Updated
May 4, 2016
NCT07436429
NCT07429227
NCT01311323
NCT06543082
NCT06535568
NCT07032389
Lead Sponsor
Sanofi
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions